Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Psychotic symptoms in 16p11.2 copy-number variant carriers.

Jutla A, Turner JB, Green Snyder L, Chung WK, Veenstra-VanderWeele J.

Autism Res. 2019 Nov 14. doi: 10.1002/aur.2232. [Epub ahead of print]

PMID:
31724820
2.

Lack of Associations Between Dietary Intake and Gastrointestinal Symptoms in Autism Spectrum Disorder.

Ferguson BJ, Dovgan K, Severns D, Martin S, Marler S, Gross Margolis K, Bauman ML, Veenstra-VanderWeele J, Sohl K, Beversdorf DQ.

Front Psychiatry. 2019 Jul 25;10:528. doi: 10.3389/fpsyt.2019.00528. eCollection 2019.

3.

The Architecture of Autism Spectrum Disorder Risk: What Do We Know, and Where Do We Go From Here?

Jutla A, Reed H, Veenstra-VanderWeele J.

JAMA Psychiatry. 2019 Jul 17. doi: 10.1001/jamapsychiatry.2019.1375. [Epub ahead of print] No abstract available.

PMID:
31314055
4.

Differential Patterns of Visual Sensory Alteration Underlying Face Emotion Recognition Impairment and Motion Perception Deficits in Schizophrenia and Autism Spectrum Disorder.

Martínez A, Tobe R, Dias EC, Ardekani BA, Veenstra-VanderWeele J, Patel G, Breland M, Lieval A, Silipo G, Javitt DC.

Biol Psychiatry. 2019 Oct 1;86(7):557-567. doi: 10.1016/j.biopsych.2019.05.016. Epub 2019 May 29.

PMID:
31301757
5.

Pharmacogenetics of Metformin for Medication-Induced Weight Gain in Autism Spectrum Disorder.

Garfunkel D, Anagnostou EA, Aman MG, Handen BL, Sanders KB, Macklin EA, Chan J, Veenstra-VanderWeele J.

J Child Adolesc Psychopharmacol. 2019 Aug;29(6):448-455. doi: 10.1089/cap.2018.0171. Epub 2019 Jun 12.

PMID:
31188026
6.

Enhanced Social Dominance and Altered Neuronal Excitability in the Prefrontal Cortex of Male KCC2b Mutant Mice.

Anacker AMJ, Moran JT, Santarelli S, Forsberg CG, Rogers TD, Stanwood GD, Hall BJ, Delpire E, Veenstra-VanderWeele J, Saxe MD.

Autism Res. 2019 May;12(5):732-743. doi: 10.1002/aur.2098. Epub 2019 Apr 12.

PMID:
30977597
7.

Whole Blood Serotonin Levels and Platelet 5-HT2A Binding in Autism Spectrum Disorder.

Aaron E, Montgomery A, Ren X, Guter S, Anderson G, Carneiro AMD, Jacob S, Mosconi M, Pandey GN, Cook E, Veenstra-VanderWeele J.

J Autism Dev Disord. 2019 Jun;49(6):2417-2425. doi: 10.1007/s10803-019-03989-z.

PMID:
30927179
8.

Inpatient Psychiatric Treatment of Serious Behavioral Problems in Children with Autism Spectrum Disorder (ASD): Specialized Versus General Inpatient Units.

Taylor BJ, Sanders KB, Kyle M, Pedersen KA, Veenstra-Vanderweele J, Siegel M.

J Autism Dev Disord. 2019 Mar;49(3):1242-1249. doi: 10.1007/s10803-018-3816-2.

PMID:
30465295
9.

Maternal Serotonin Levels Are Associated With Cognitive Ability and Core Symptoms in Autism Spectrum Disorder.

Montgomery AK, Shuffrey LC, Guter SJ, Anderson GM, Jacob S, Mosconi MW, Sweeney JA, Turner JB, Sutcliffe JS, Cook EH Jr, Veenstra-VanderWeele J.

J Am Acad Child Adolesc Psychiatry. 2018 Nov;57(11):867-875. doi: 10.1016/j.jaac.2018.06.025. Epub 2018 Sep 24.

10.

Development of a Brief Parent-Report Screen for Common Gastrointestinal Disorders in Autism Spectrum Disorder.

Margolis KG, Buie TM, Turner JB, Silberman AE, Feldman JF, Murray KF, McSwiggan-Hardin M, Levy J, Bauman ML, Veenstra-VanderWeele J, Whitaker AH, Winter HS.

J Autism Dev Disord. 2019 Jan;49(1):349-362. doi: 10.1007/s10803-018-3767-7.

PMID:
30350113
11.

p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse.

Robson MJ, Quinlan MA, Margolis KG, Gajewski-Kurdziel PA, Veenstra-VanderWeele J, Gershon MD, Watterson DM, Blakely RD.

Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10245-E10254. doi: 10.1073/pnas.1809137115. Epub 2018 Oct 8.

12.

Dr. Handen et al. Reply.

Handen BL, Veenstra-VanderWeele J, Anagnostou E, Aman MG.

J Am Acad Child Adolesc Psychiatry. 2018 Oct;57(10):793-795. doi: 10.1016/j.jaac.2018.08.005.

PMID:
30274655
13.

What's in a Name? Moving to Neuroscience-Based Nomenclature in Pediatric Psychopharmacology.

Sultan RS, Correll CU, Zohar J, Zalsman G, Veenstra-VanderWeele J.

J Am Acad Child Adolesc Psychiatry. 2018 Oct;57(10):719-721. doi: 10.1016/j.jaac.2018.05.024.

14.

Autism spectrum disorder.

Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J.

Lancet. 2018 Aug 11;392(10146):508-520. doi: 10.1016/S0140-6736(18)31129-2. Epub 2018 Aug 2. Review.

PMID:
30078460
15.

Systematic review and guide to management of core and psychiatric symptoms in youth with autism.

Ameis SH, Kassee C, Corbett-Dick P, Cole L, Dadhwal S, Lai MC, Veenstra-VanderWeele J, Correll CU.

Acta Psychiatr Scand. 2018 Nov;138(5):379-400. doi: 10.1111/acps.12918. Epub 2018 Jun 14.

PMID:
29904907
16.

Neuronal excitatory amino acid transporter EAAT3: Emerging functions in health and disease.

Underhill SM, Ingram SL, Ahmari SE, Veenstra-VanderWeele J, Amara SG.

Neurochem Int. 2019 Feb;123:69-76. doi: 10.1016/j.neuint.2018.05.012. Epub 2018 May 22. No abstract available.

PMID:
29800605
17.

Recognizing the Problem of Suicidality in Autism Spectrum Disorder.

Veenstra-VanderWeele J.

J Am Acad Child Adolesc Psychiatry. 2018 May;57(5):302-303. doi: 10.1016/j.jaac.2018.03.003.

PMID:
29706156
18.

Analysis of neuroanatomical differences in mice with genetically modified serotonin transporters assessed by structural magnetic resonance imaging.

Ellegood J, Yee Y, Kerr TM, Muller CL, Blakely RD, Henkelman RM, Veenstra-VanderWeele J, Lerch JP.

Mol Autism. 2018 Apr 10;9:24. doi: 10.1186/s13229-018-0210-z. eCollection 2018.

19.

Effects of Metformin on Spatial and Verbal Memory in Children with ASD and Overweight Associated with Atypical Antipsychotic Use.

Aman MG, Hollway JA, Veenstra-VanderWeele J, Handen BL, Sanders KB, Chan J, Macklin E, Arnold LE, Wong T, Newsom C, Hastie Adams R, Marler S, Peleg N, Anagnostou EA.

J Child Adolesc Psychopharmacol. 2018 May;28(4):266-273. doi: 10.1089/cap.2017.0072. Epub 2018 Apr 5.

20.

The Emerging Clinical Neuroscience of Autism Spectrum Disorder: A Review.

Muhle RA, Reed HE, Stratigos KA, Veenstra-VanderWeele J.

JAMA Psychiatry. 2018 May 1;75(5):514-523. doi: 10.1001/jamapsychiatry.2017.4685. Review.

PMID:
29590280
21.

Evaluation and Management of Self-injury in a Child With a Rare Genomic Variant.

Muhle RA, Reed HE, Aguayo P, Veenstra-VanderWeele J.

JAMA Psychiatry. 2018 May 1;75(5):524-525. doi: 10.1001/jamapsychiatry.2017.4677. No abstract available.

PMID:
29590276
22.

Clinical Diagnostic Genetic Testing for Individuals With Developmental Disorders.

Muhle RA, Reed HE, Vo LC, Mehta S, McGuire K, Veenstra-VanderWeele J, Pedapati E.

J Am Acad Child Adolesc Psychiatry. 2017 Nov;56(11):910-913. doi: 10.1016/j.jaac.2017.09.418. No abstract available.

PMID:
29096769
23.

A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension.

Handen BL, Anagnostou E, Aman MG, Sanders KB, Chan J, Hollway JA, Brian J, Arnold LE, Capano L, Williams C, Hellings JA, Butter E, Mankad D, Tumuluru R, Kettel J, Newsom CR, Peleg N, Odrobina D, McAuliffe-Bellin S, Marler S, Wong T, Wagner A, Hadjiyannakis S, Macklin EA, Veenstra-VanderWeele J.

J Am Acad Child Adolesc Psychiatry. 2017 Oct;56(10):849-856.e6. doi: 10.1016/j.jaac.2017.07.790. Epub 2017 Aug 19.

PMID:
28942807
24.

Spatial gene expression analysis of neuroanatomical differences in mouse models.

Fernandes DJ, Ellegood J, Askalan R, Blakely RD, Dicicco-Bloom E, Egan SE, Osborne LR, Powell CM, Raznahan A, Robins DM, Salter MW, Sengar AS, Veenstra-VanderWeele J, Henkelman RM, Lerch JP.

Neuroimage. 2017 Dec;163:220-230. doi: 10.1016/j.neuroimage.2017.08.065. Epub 2017 Sep 4.

PMID:
28882630
25.

Effects of a social stimulus on gene expression in a mouse model of fragile X syndrome.

Rogers TD, Anacker AMJ, Kerr TM, Forsberg CG, Wang J, Zhang B, Veenstra-VanderWeele J.

Mol Autism. 2017 Jun 23;8:30. doi: 10.1186/s13229-017-0148-6. eCollection 2017.

26.

Translation in fragile X: no home runs in the first at-bat.

Veenstra-VanderWeele J.

J Neurodev Disord. 2017 Jun 12;9:21. doi: 10.1186/s11689-017-9204-y. eCollection 2017. No abstract available.

27.

Blockade of the 5-HT transporter contributes to the behavioural, neuronal and molecular effects of cocaine.

Simmler LD, Anacker AMJ, Levin MH, Vaswani NM, Gresch PJ, Nackenoff AG, Anastasio NC, Stutz SJ, Cunningham KA, Wang J, Zhang B, Henry LK, Stewart A, Veenstra-VanderWeele J, Blakely RD.

Br J Pharmacol. 2017 Aug;174(16):2716-2738. doi: 10.1111/bph.13899. Epub 2017 Jul 11.

28.

OCD candidate gene SLC1A1/EAAT3 impacts basal ganglia-mediated activity and stereotypic behavior.

Zike ID, Chohan MO, Kopelman JM, Krasnow EN, Flicker D, Nautiyal KM, Bubser M, Kellendonk C, Jones CK, Stanwood G, Tanaka KF, Moore H, Ahmari SE, Veenstra-VanderWeele J.

Proc Natl Acad Sci U S A. 2017 May 30;114(22):5719-5724. doi: 10.1073/pnas.1701736114. Epub 2017 May 15.

29.

Is there sexual dimorphism of hyperserotonemia in autism spectrum disorder?

Shuffrey LC, Guter SJ, Delaney S, Jacob S, Anderson GM, Sutcliffe JS, Cook EH, Veenstra-VanderWeele J.

Autism Res. 2017 Aug;10(8):1417-1423. doi: 10.1002/aur.1791. Epub 2017 Apr 12.

30.

An autism-associated serotonin transporter variant disrupts multisensory processing.

Siemann JK, Muller CL, Forsberg CG, Blakely RD, Veenstra-VanderWeele J, Wallace MT.

Transl Psychiatry. 2017 Mar 21;7(3):e1067. doi: 10.1038/tp.2017.17.

31.

Association of Rigid-Compulsive Behavior with Functional Constipation in Autism Spectrum Disorder.

Marler S, Ferguson BJ, Lee EB, Peters B, Williams KC, McDonnell E, Macklin EA, Levitt P, Margolis KG, Beversdorf DQ, Veenstra-VanderWeele J.

J Autism Dev Disord. 2017 Jun;47(6):1673-1681. doi: 10.1007/s10803-017-3084-6.

32.

Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder.

Luna RA, Oezguen N, Balderas M, Venkatachalam A, Runge JK, Versalovic J, Veenstra-VanderWeele J, Anderson GM, Savidge T, Williams KC.

Cell Mol Gastroenterol Hepatol. 2016 Dec 11;3(2):218-230. doi: 10.1016/j.jcmgh.2016.11.008. eCollection 2017 Mar.

33.

Medical Conditions and Demographic, Service and Clinical Factors Associated with Atypical Antipsychotic Medication Use Among Children with An Autism Spectrum Disorder.

Lake JK, Denton D, Lunsky Y, Shui AM, Veenstra-VanderWeele J, Anagnostou E.

J Autism Dev Disord. 2017 May;47(5):1391-1402. doi: 10.1007/s10803-017-3058-8.

PMID:
28210827
34.

Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial.

Veenstra-VanderWeele J, Cook EH, King BH, Zarevics P, Cherubini M, Walton-Bowen K, Bear MF, Wang PP, Carpenter RL.

Neuropsychopharmacology. 2017 Jun;42(7):1390-1398. doi: 10.1038/npp.2016.237. Epub 2016 Oct 17.

35.

Rodent models of obsessive compulsive disorder: Evaluating validity to interpret emerging neurobiology.

Zike I, Xu T, Hong N, Veenstra-VanderWeele J.

Neuroscience. 2017 Mar 14;345:256-273. doi: 10.1016/j.neuroscience.2016.09.012. Epub 2016 Sep 16. Review.

36.

Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.

Anagnostou E, Aman MG, Handen BL, Sanders KB, Shui A, Hollway JA, Brian J, Arnold LE, Capano L, Hellings JA, Butter E, Mankad D, Tumuluru R, Kettel J, Newsom CR, Hadjiyannakis S, Peleg N, Odrobina D, McAuliffe-Bellin S, Zakroysky P, Marler S, Wagner A, Wong T, Macklin EA, Veenstra-VanderWeele J.

JAMA Psychiatry. 2016 Sep 1;73(9):928-37. doi: 10.1001/jamapsychiatry.2016.1232. Erratum in: JAMA Psychiatry. 2016 Dec 1;73(12):1295.

PMID:
27556593
37.

Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment.

Muller CL, Anacker AM, Rogers TD, Goeden N, Keller EH, Forsberg CG, Kerr TM, Wender C, Anderson GM, Stanwood GD, Blakely RD, Bonnin A, Veenstra-VanderWeele J.

Neuropsychopharmacology. 2017 Jan;42(2):427-436. doi: 10.1038/npp.2016.166. Epub 2016 Aug 23.

38.

Psychophysiological Associations with Gastrointestinal Symptomatology in Autism Spectrum Disorder.

Ferguson BJ, Marler S, Altstein LL, Lee EB, Akers J, Sohl K, McLaughlin A, Hartnett K, Kille B, Mazurek M, Macklin EA, McDonnell E, Barstow M, Bauman ML, Margolis KG, Veenstra-VanderWeele J, Beversdorf DQ.

Autism Res. 2017 Feb;10(2):276-288. doi: 10.1002/aur.1646. Epub 2016 Jun 20.

39.

Associations between cytokines, endocrine stress response, and gastrointestinal symptoms in autism spectrum disorder.

Ferguson BJ, Marler S, Altstein LL, Lee EB, Mazurek MO, McLaughlin A, Macklin EA, McDonnell E, Davis DJ, Belenchia AM, Gillespie CH, Peterson CA, Bauman ML, Margolis KG, Veenstra-VanderWeele J, Beversdorf DQ.

Brain Behav Immun. 2016 Nov;58:57-62. doi: 10.1016/j.bbi.2016.05.009. Epub 2016 May 12.

40.

Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function.

Margolis KG, Li Z, Stevanovic K, Saurman V, Israelyan N, Anderson GM, Snyder I, Veenstra-VanderWeele J, Blakely RD, Gershon MD.

J Clin Invest. 2016 Jun 1;126(6):2221-35. doi: 10.1172/JCI84877. Epub 2016 Apr 25.

41.

Pattern of Diagnosis and Co-occurring Symptoms in Adopted Children With Autism Spectrum Disorder.

Ezell J, Shui A, Sanders K, Veenstra-VanderWeele J.

Pediatrics. 2016 Feb;137 Suppl 2:S90-7. doi: 10.1542/peds.2015-2851G.

42.

Irritability and Problem Behavior in Autism Spectrum Disorder: A Practice Pathway for Pediatric Primary Care.

McGuire K, Fung LK, Hagopian L, Vasa RA, Mahajan R, Bernal P, Silberman AE, Wolfe A, Coury DL, Hardan AY, Veenstra-VanderWeele J, Whitaker AH.

Pediatrics. 2016 Feb;137 Suppl 2:S136-48. doi: 10.1542/peds.2015-2851L. Epub 2016 Feb 1.

43.

Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis.

Fung LK, Mahajan R, Nozzolillo A, Bernal P, Krasner A, Jo B, Coury D, Whitaker A, Veenstra-Vanderweele J, Hardan AY.

Pediatrics. 2016 Feb;137 Suppl 2:S124-35. doi: 10.1542/peds.2015-2851K. Review.

44.

Medical and Behavioral Correlates of Depression History in Children and Adolescents With Autism Spectrum Disorder.

Greenlee JL, Mosley AS, Shui AM, Veenstra-VanderWeele J, Gotham KO.

Pediatrics. 2016 Feb;137 Suppl 2:S105-14. doi: 10.1542/peds.2015-2851I.

45.

Attention Finally Being Paid to Girls at Risk of Autism.

Bishop SL, Veenstra-VanderWeele J, Sanders SJ.

J Am Acad Child Adolesc Psychiatry. 2016 Mar;55(3):159-60. doi: 10.1016/j.jaac.2015.12.013. No abstract available.

PMID:
26903248
46.

Rigid, Inflexible Approach Results in No Recommendation for Autism Screening.

Veenstra-VanderWeele J, McGuire K.

JAMA Psychiatry. 2016 Apr;73(4):327-8. doi: 10.1001/jamapsychiatry.2016.0143. No abstract available.

PMID:
26881781
47.

Following the Trail From Genotype to Phenotypes.

Lord C, Veenstra-VanderWeele J.

JAMA Psychiatry. 2016 Jan;73(1):7-8. doi: 10.1001/jamapsychiatry.2015.2344. No abstract available.

PMID:
26630619
48.

The serotonin system in autism spectrum disorder: From biomarker to animal models.

Muller CL, Anacker AMJ, Veenstra-VanderWeele J.

Neuroscience. 2016 May 3;321:24-41. doi: 10.1016/j.neuroscience.2015.11.010. Epub 2015 Nov 11. Review.

49.

Brief Report: Whole Blood Serotonin Levels and Gastrointestinal Symptoms in Autism Spectrum Disorder.

Marler S, Ferguson BJ, Lee EB, Peters B, Williams KC, McDonnell E, Macklin EA, Levitt P, Gillespie CH, Anderson GM, Margolis KG, Beversdorf DQ, Veenstra-VanderWeele J.

J Autism Dev Disord. 2016 Mar;46(3):1124-30. doi: 10.1007/s10803-015-2646-8.

50.

Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse.

Nackenoff AG, Moussa-Tooks AB, McMeekin AM, Veenstra-VanderWeele J, Blakely RD.

Neuropsychopharmacology. 2016 Jun;41(7):1733-41. doi: 10.1038/npp.2015.335. Epub 2015 Oct 30.

Supplemental Content

Loading ...
Support Center